Sphingolipids and cell signalling

Journal of Inherited Metabolic Disease

Volumn 21, Issue 5, 1998, Pages 472-480

  Fredman, P ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CYTOKINE; SPHINGOLIPID; SPHINGOSINE;

APOPTOSIS; CELL ACTIVITY; CONFERENCE PAPER; GROWTH REGULATION; HUMAN; INTRACELLULAR TRANSPORT; LIPID METABOLISM; SIGNAL PROCESSING; STORAGE DISEASE;

ANIMALS; CELL COMMUNICATION; HUMANS; SIGNAL TRANSDUCTION; SPHINGOLIPIDOSES; SPHINGOLIPIDS;

EID: 0031846977     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005454602454     Document Type: Conference Paper

References (38)

1. Benjamins JA, Nedelkoska L (1994) Maintenance of membrane sheets by cultured oligodendrocytes requires continuous microtubule turnover and Golgi transport. Neurochem Res 19: 631-639.
2. Boneh A (1995) Possible role for protein kinase C in the pathogenesis of inborn errors of metabolism. J Cell Biochem 59: 27-32.
3. Boucher LM, Wiegman K, Futterere A, et al (1995) CD28 signals through acidic sphingomyelinase. J Exp Med 181: 2059-2068.
4. Buschard K, Josefsen K, Hansen SV, et al (1994) Sulphatide in islets of Langerhans and in organs affected in diabetic late complications. Diabetologia 37: 1000-1006.
5. Buschard K, Diamant M, Bovin LE, Mansson JE, Fredman P, Bendtzen K (1996) Sulphatide and its precursor galacatosylceramide influence the production of cytokines in human mononuclear cells. APMIS 104: 938-944.
6. Chu JW, Sharom FJ (1995) Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation. Immunology 84: 396-403.
7. Cifone MG, De Maria R, Roncaioli P, et al (1994) Apoptotic signalling through CD95 (Fas/ Apo-1) activates an acidic sphingomyelinase. J Exp Med 177: 1547-1552.
8. Coetzee T, Fujita N, Dupree J, et al (1996) Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86: 209-219.
9. Constantin G, Laudanna C, Baron P, Berton G (1994) Sulphatides trigger cytokine gene expression and secretion in human monocytes. FEBS Lett 350: 66-70.
10. Coroneos E, Wang Y, Panuska JR, Templeton DJ, Kester M (1996) Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascade. Biochem J 15: 13-17.
11. Fiedler K, Kobayashi T, Kurzchalia TV, Simons K (1993) Sphingolipid-enriched, detergent-insoluble complexes in protein sorting in epithelial cells. Biochemistry 32: 6365-6373.
12. Fredman P (1993) Glycosphingolipid tumour antigens. Adv Lipid Res 25: 213-234.
13. Gillard BK, Harrell G, Marcus DM (1996) Pathway of glycosphingolipid biosynthesis in SW13 cells in the presence and absence of vimentin intermediate filaments. Glycobiology 6: 33-42.
14. Giudici ML, Vos JP, Marchesini S, Van Golde LM, Lopes-Cardozo M (1992) Uptake and metabolism of fluorescent ceramide analogs by rat oligodendrocytes in culture. FEBS Lett 314: 471-476.
15. Hagberg B, Sourander P, Svennerholm L (1962) Sulfatide lipidosis in childhood: Report of a case investigation during life and at autopsy. Am J Dis Child 104: 644-656.
16. Hakomori SI, Igarashi Y (1995) Functional role of glycosphingolipids in cell recognition and signalling. J Biochem 118: 1091-1103.
17. Hanada K (1992) Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids. J Biol Chem 267: 23527-23533.
18. Hannun YA (1996) Functions of ceramide in co-ordinating cellular responses to stress. Science 274: 1855-1859.
19. Heitger A, Ladisch S (1996) Gangliosides block antigen presentation by human monocytes. Biochim Biophys Acta 1303: 161-168.
20. Higashi H, Suzuki Y, Mukaida N, Takahashi N, Miyamoto D, Matsushima K (1997) Intervention in endotoxin shock by sulphatide (I3SO3-GalCer) with a concomitant reduction in tumour necrosis factor alpha production. Infect Immun 65: 1223-1227.
21. Inoue A, Koh CS, Yanigasawa N, Taketomi T, Ishihara Y (1996) Suppression of Theiler's murine encephalomyelitis virus induced demyelinating disease by administration of gangliosides. J Neuroimmunol 64: 45-53.
22. Kim T, Fiedler K, Madison DL, Kreuger WH, Pfeiffer S (1995) Cloning and characterization of MVP17: a developmentally regulated myelin protein in oligodendrocytes. J Neursci Res 42: 413-422.
23. Kolter T, Sandhoff K (1998) Glycosphingolipid degradation and animal models of GM2-gangliosidoses. J Inher Metab Dis 21: 548-563.
24. Laudanna C, Constantin G, Baron P, et al (1994) Sulphatide triggers increase of cytosolic free calcium and enhanced expression of tumour necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signalling molecule. J Biol Chem 269: 4021-4026.
25. Laulederkind SJF, Bielawska A, Raghow R, Hannun YA, Ballau LR (1995) Ceramide induces interleukin 6 gene expression in human fibroblasts. J Exp Med 182: 599-604.
26. Liu J, Mathias S, Yang Z, Kolesnick RN (1994) Renaturation and TNFα stimulation of a 97kDa ceramide-activated protein kinase. J Biol Chem 269: 3047-3052.
27. Merill AH, Schmelz EM, Dillehay D, et al (1997) Sphingolipids: the enigmatic lipid class: biochemistry, physiology and pathophysiology. Toxicol Appl Pharmacol 142: 208-225.
28. Meyer zu, Heringdrof D, van Koppen CJ, Windorfer B, Himmel HM, Jakobs KH (1996) Calcium signalling by G protein-coupled sphingolipid receptors in bovine aortic endothelial cells. Naunyn-Schmidebergs Arch Pharmacol 354: 397-403.
29. Michelakakis H, Spanou S, Kondyli A, et al (1996) Plasma tumour necrosis factor-α (TNF-α) levels in Gaucher disease. Biochim Biophys Acta 1317: 219-222.
30. Olivera A, Spiegel S (1994) Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365: 557-560.
31. Santana P, Peña LA, Haimowitz-Friedman A, et al (1996) Acid sphingomylinase-deficient human lymphoblasts and mice are defective in radiation induced apoptosis. Cell 86: 189-199.
32. Siegel G, Agranoff BW, Albers RW, Molinoff PB (eds) (1994) Lipids. Basic Neurochemistry, New York: Raven Press, 97-116.
33. Slegers H, Joniau M (1996) Lipopolysaccharide-enhanced expression of interleukin 6 dibutyryl cyclic AP-differentiated rat C6 glioma. J Neurochem 66: 466-473.
34. Spiegel S, Milstien (1995) Sphingolipid metabolites: members of a new class of lipid second messengers. J Membr Biol 146: 225-237.
35. Suzuki K, Månsson JE (1998) Animal models of lysosomal disease: an overview. J Inher Metab Dis 21: 540-547.
36. Van der Bijl, Lopes-Cardozo M, van Meer G (1996) Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells. J Cell Biol 132: 813-821.
37. Van Meer G, Burger KNJ (1992) Sphingolipid trafficking-sorted out? Trends Cell Biol 2: 332-337.
38. Walkley SU, Siegel DA, Dobrenis K (1995) GM2 ganglioside and pyramidal neuron dendritogenesis. Neurochem Res 20: 1287-1299.